Logos Global Management LP Relay Therapeutics, Inc. Transaction History
Logos Global Management LP
- $1.07 Billion
- Q2 2024
A detailed history of Logos Global Management LP transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 1,300,000 shares of RLAY stock, worth $7.72 Million. This represents 0.8% of its overall portfolio holdings.
Number of Shares
1,300,000
Previous 1,300,000
-0.0%
Holding current value
$7.72 Million
Previous $8.48 Million
-0.0%
% of portfolio
0.8%
Previous 0.8%
Shares
3 transactions
Others Institutions Holding RLAY
# of Institutions
187Shares Held
132MCall Options Held
16.7KPut Options Held
18K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$166 Million1.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$69.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$62.6 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY8.45MShares$50.2 Million4.75% of portfolio
-
Bellevue Group Ag Kuesnacht, V86.38MShares$37.9 Million0.7% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $714M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...